Cardiologists and Surgeons Meet for Heart Valve Summit

Interventional cardiologists and surgeons sat down together to discuss the advances in percutaneous heart valve technology at a jointly-sponsored seminar in Chicago, reflecting a newfound recognition by surgeons of the need to embrace these new procedures.

Last year marked the 50th anniversary of the first reported successful surgical treatment of cardiac valvular disease, and in that half-century, surgeons have come to own this practice area. Twenty years ago, however, interventional cardiologists fired the initial shots across the surgeons' bows when the first balloon aortic valvuloplasty procedure was performed. Surgeons remained largely unthreatened, because many patients who underwent these early interventional procedures suffered from early valve restenosis within one year of the procedure.

It took cardiologists a while to launch another attempt at interventional heart valve treatment, and in 2002, the first aortic...

More from Innovation

More from In Vivo

Rising Leaders 2025: Doxie Jordan, From UNC Graduate To Global Market Strategist

 
• By 

Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy

Podcast: Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients

 

Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.

Behind The Buyout: Dispatches From The Dealmaking Table

 
• By 

In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.